Editorial overview of the special issue on application of tissue chips in toxicology.
作者信息
Rusyn Ivan, Roth Adrian
机构信息
Department of Veterinary Integrative Biosciences, College of veterinary Medicine and Biomedical Sciences, Texas A&M University, College Station, TX, USA.
Product Development Safety, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel, Switzerland.
出版信息
Toxicology. 2021 Feb 28;450:152687. doi: 10.1016/j.tox.2021.152687. Epub 2021 Jan 20.
Abstract
摘要
相似文献
1
Editorial overview of the special issue on application of tissue chips in toxicology.组织芯片在毒理学中应用特刊的编辑概述
Toxicology. 2021 Feb 28;450:152687. doi: 10.1016/j.tox.2021.152687. Epub 2021 Jan 20.
2
A 3D microfluidic liver model for high throughput compound toxicity screening in the OrganoPlate®.一种用于 OrganoPlate®高通量化合物毒性筛选的 3D 微流控肝脏模型。
Toxicology. 2021 Feb 28;450:152667. doi: 10.1016/j.tox.2020.152667. Epub 2021 Jan 6.
3
One-Step Seeding of Neural Stem Cells with Vitronectin-Supplemented Medium for High-Throughput Screening Assays.使用含玻连蛋白的培养基对神经干细胞进行一步接种以用于高通量筛选分析
J Biomol Screen. 2016 Dec;21(10):1112-1124. doi: 10.1177/1087057116670068. Epub 2016 Sep 26.
4
Cardiomyocytes from human pluripotent stem cells: From laboratory curiosity to industrial biomedical platform.源自人类多能干细胞的心肌细胞：从实验室的新奇事物到工业生物医学平台。
Biochim Biophys Acta. 2016 Jul;1863(7 Pt B):1728-48. doi: 10.1016/j.bbamcr.2015.10.014. Epub 2015 Oct 31.
5
High-Content Assay Multiplexing for Toxicity Screening in Induced Pluripotent Stem Cell-Derived Cardiomyocytes and Hepatocytes.用于诱导多能干细胞衍生的心肌细胞和肝细胞毒性筛选的高内涵分析多重检测法
Assay Drug Dev Technol. 2015 Nov;13(9):529-46. doi: 10.1089/adt.2015.659. Epub 2015 Nov 5.
6
High-Throughput Cell Toxicity Assays.高通量细胞毒性测定
Methods Mol Biol. 2016;1439:245-62. doi: 10.1007/978-1-4939-3673-1_16.
7
Human iPS Cell-Derived Patient Tissues and 3D Cell Culture Part 1: Target Identification and Lead Optimization.人诱导多能干细胞衍生的患者组织和 3D 细胞培养物第一部分：靶标鉴定和先导化合物优化。
SLAS Technol. 2019 Feb;24(1):3-17. doi: 10.1177/2472630318803277. Epub 2018 Oct 4.
8
Screening out irrelevant cell-based models of disease.筛选与疾病无关的基于细胞的模型。
Nat Rev Drug Discov. 2016 Nov;15(11):751-769. doi: 10.1038/nrd.2016.175. Epub 2016 Sep 12.
9
Phenotypic Characterization of Toxic Compound Effects on Liver Spheroids Derived from iPSC Using Confocal Imaging and Three-Dimensional Image Analysis.使用共聚焦成像和三维图像分析对源自诱导多能干细胞的肝类器官中有毒化合物作用的表型特征分析
Assay Drug Dev Technol. 2016 Sep;14(7):381-94. doi: 10.1089/adt.2016.729. Epub 2016 Aug 5.
10
Stem cells are the most sensitive screening tool to identify toxicity of GATA4-targeted novel small-molecule compounds.干细胞是鉴定 GATA4 靶向新型小分子化合物毒性的最敏感筛选工具。
Arch Toxicol. 2018 Sep;92(9):2897-2911. doi: 10.1007/s00204-018-2257-1. Epub 2018 Jul 9.
引用本文的文献
1
Technical evaluation and standardization of the human thyroid microtissue assay.人甲状腺微组织检测的技术评估与标准化
Toxicol Sci. 2024 Apr 29;199(1):89-107. doi: 10.1093/toxsci/kfae014.
2
Metabolites in the regulatory risk assessment of pesticides in the EU.欧盟农药监管风险评估中的代谢物
Front Toxicol. 2023 Dec 19;5:1304885. doi: 10.3389/ftox.2023.1304885. eCollection 2023.
3
A New Immortalized Human Alveolar Epithelial Cell Model to Study Lung Injury and Toxicity on a Breathing Lung-On-Chip System.一种用于在呼吸式肺芯片系统上研究肺损伤和毒性的新型永生化人肺泡上皮细胞模型。
Front Toxicol. 2022 Jun 17;4:840606. doi: 10.3389/ftox.2022.840606. eCollection 2022.
4
Implementing organ-on-chip in a next-generation risk assessment of chemicals: a review.在下一代化学品风险评估中实施器官芯片：综述。
Arch Toxicol. 2022 Mar;96(3):711-741. doi: 10.1007/s00204-022-03234-0. Epub 2022 Feb 1.
5
Scientific Opinion of the Scientific Panel on Plant Protection Products and their Residues (PPR Panel) on testing and interpretation of comparative metabolism studies.植物保护产品及其残留科学小组（PPR小组）关于比较代谢研究的测试与解读的科学意见。
EFSA J. 2021 Dec 23;19(12):e06970. doi: 10.2903/j.efsa.2021.6970. eCollection 2021 Dec.
本文引用的文献
1
Physiologically inspired culture medium prolongs the lifetime and insulin sensitivity of human hepatocytes in micropatterned co-cultures.受生理启发的培养基可延长微图案共培养体系中人类肝细胞的寿命和胰岛素敏感性。
Toxicology. 2021 Feb 15;449:152662. doi: 10.1016/j.tox.2020.152662. Epub 2020 Dec 24.
2
A 3D microfluidic liver model for high throughput compound toxicity screening in the OrganoPlate®.一种用于 OrganoPlate®高通量化合物毒性筛选的 3D 微流控肝脏模型。
Toxicology. 2021 Feb 28;450:152667. doi: 10.1016/j.tox.2020.152667. Epub 2021 Jan 6.
3
Analysis of reproducibility and robustness of a human microfluidic four-cell liver acinus microphysiology system (LAMPS).分析人类微流控四细胞肝小叶微生理系统 (LAMPS) 的重现性和稳健性。
Toxicology. 2021 Jan 30;448:152651. doi: 10.1016/j.tox.2020.152651. Epub 2020 Dec 8.
4
Characterization of application scenario-dependent pharmacokinetics and pharmacodynamic properties of permethrin and hyperforin in a dynamic skin and liver multi-organ-chip model.在动态皮肤和肝脏多器官芯片模型中，描述氯菊酯和贯叶连翘素的药代动力学和药效学性质与应用场景相关的特征。
Toxicology. 2021 Jan 30;448:152637. doi: 10.1016/j.tox.2020.152637. Epub 2020 Nov 18.
5
Development and characterization of rat duodenal organoids for ADME and toxicology applications.用于 ADME 和毒理学应用的大鼠十二指肠类器官的开发和特性鉴定。
Toxicology. 2020 Dec 15;446:152614. doi: 10.1016/j.tox.2020.152614. Epub 2020 Oct 24.
6
Human in vitro vascularized micro-organ and micro-tumor models are reproducible organ-on-a-chip platforms for studies of anticancer drugs.人类体外血管化微器官和微肿瘤模型是可重现的类器官芯片平台，可用于研究抗癌药物。
Toxicology. 2020 Dec 1;445:152601. doi: 10.1016/j.tox.2020.152601. Epub 2020 Sep 24.
7
Microphysiological system modeling of ochratoxin A-associated nephrotoxicity.微生理系统对赭曲霉毒素 A 相关性肾毒性的建模研究。
Toxicology. 2020 Nov;444:152582. doi: 10.1016/j.tox.2020.152582. Epub 2020 Sep 6.
8
Organs-on-a-Chip.器官芯片。
Adv Exp Med Biol. 2020;1230:27-42. doi: 10.1007/978-3-030-36588-2_3.
9
Developing in vitro assays to transform gastrointestinal safety assessment: potential for microphysiological systems.开发体外试验以转变胃肠道安全性评估：微生理系统的潜力。
Lab Chip. 2020 Apr 7;20(7):1177-1190. doi: 10.1039/c9lc01107b. Epub 2020 Mar 4.
10
Biology-inspired microphysiological systems to advance patient benefit and animal welfare in drug development.受生物学启发的微生理系统可提高药物开发中患者获益和动物福利。
ALTEX. 2020;37(3):365-394. doi: 10.14573/altex.2001241. Epub 2020 Feb 28.
Zotero 插件